retatrutide ly3437943 parkinson's disease clinical trial 🔬 — why cardiology and the gym are paying attention For GLP medications are all anyone’s

(2023) 53:e2250233

Critical Biomarkers to Monitor Before and During GLP-1 Therapy Baseline lab work establishes your metabolic starting point and informs safe medication selection and dosing

This observation implies that not all patients need to take on the highest dose to have the beneficial effects of liraglutide

All trials analyzed the composite of 3 major adverse cardiovascular events (MACE), which included cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke, except the lixisenatide study that considered 4-point MACE, which also included hospitalization for heart failure (Table 1).5764 Although all the studies with arGLP-1 have demonstrated cardiovascular safety (noninferiority vs